Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TransMedics

TransMedics?uq=PEM9b6PF
1998 FOUNDED
PRIVATE STATUS
81-90 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
20 INVESTORS
Description

Developer of organ transplant technologies designed to increase the number of transplantable organs worldwide. The company's organ transplant technologies include a portable warm blood perfusion system that helps for a new type of organ transplant and maintain organs in a warm, functioning state outside of the body during transfer from organ donor to recipient, enabling patients to find the required organs right in time and get them transplanted at a low cost.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 200 Minuteman Road
  • Suite 302
  • Andover, MA 01810
  • United States

+1 (978) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TransMedics’s full profile, request a free trial.

TransMedics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC 00000 Completed Profitable
15. Later Stage VC (Series F) 11-Jul-2016 000.00 00000 00000 Completed Profitable
14. Later Stage VC (Series F) 21-Sep-2015 00000 00000 00000 Completed Profitable
13. Later Stage VC (Series F) 03-Jun-2015 0000 00000 00000 Completed Profitable
12. Secondary Transaction - Private 00000 Completed Profitable
11. Later Stage VC (Series E) 13-Jun-2013 000.00 00000 00000 Completed Profitable
10. Later Stage VC (Series D) 16-Nov-2012 000.00 00000 0000 Completed Profitable
9. Later Stage VC (Series C) 12-Aug-2011 000.00 00000 000.00 Completed Profitable
8. Later Stage VC (Series B) 26-Feb-2010 $35.4M $147M 000.00 Completed Profitable
7. Senior Debt 31-Dec-2008 $10M $111M Completed Profitable
To view this company’s complete deal history including valuation and funding, request access »

TransMedics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series F 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series E 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.00
Series C 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B1 0,000,000 00.000000 00 00.00 00.00 00 000.00 0.000
Series B 3,771,020 $0.000100 8% $3.42 $3.42 1x $12.37 1.79%
Series A1 13,332 $0.000100 $2.5 $2.5 1x $9.68 0.01%
To view this company’s complete Cap Table, request access »

TransMedics Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioStar Ventures Venture Capital Minority 000 0000 000000 0
Ervington Investments Venture Capital Minority 000 0000 000000 0
Fayerweather Management PE/Buyout Minority 000 0000 000000 0
Inbio Ventures Venture Capital Minority 000 0000 000000 0
Lung Biotechnology VC-Backed Company Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

TransMedics Executive Team (13)

Name Title Board
Seat
Contact
Info
Waleed Hassanein MD Chief Executive Officer, President, Board Member & Founder
Stephen Gordon Chief Financial Officer
John Sullivan Vice President, Engineering
Jacqueline Sneve Vice President, Healthcare Economics & Reimbursement
John Carey Vice President, Operations

7 Former Executives

You’re viewing 5 of 13 executives. Get the full list »

TransMedics Board Members (15)

Name Representing Role Since Contact
Info
Adam Grosser Self Board Member 000 0000
David Abrams Abrams Capital Board Member 000 0000
Dmitry Kobyzev Ph.D Inbio Ventures Board Member 000 0000
Earl Collier JD Self Board Member 000 0000
Edward Basile JD Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »